This inventor holds 1 USPTO granted patent. Top assignee: Aurobindo Pharma Limited. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Nageshwar Dussa: Innovator in Pharmaceutical Chemistry
Introduction
Nageshwar Dussa is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug preparation. His work has the potential to impact the treatment of various medical conditions.
Latest Patents
Nageshwar Dussa holds a patent for the "Process for the preparation of Dolutegravir." This invention provides a method for synthesizing (R)-3-Amino-1-butanol (D)-tartarate and its conversion to Dolutegravir. The patent also outlines an improved process for preparing Dolutegravir or its pharmaceutically acceptable salts, wherein compound (XVI) is reacted with an optically active acid addition salt of (R)-3-amino-1-butanol.
Career Highlights
Nageshwar Dussa is associated with Aurobindo Pharma Limited, a leading pharmaceutical company. His work at Aurobindo Pharma has allowed him to focus on innovative drug development and contribute to the advancement of pharmaceutical sciences.
Collaborations
He has collaborated with notable colleagues, including Jagan Mohan Reddy Sanapureddy and Shankar Reddy Budidet. These collaborations have fostered a productive environment for research and innovation in the pharmaceutical sector.
Conclusion
Nageshwar Dussa's contributions to pharmaceutical chemistry, particularly through his patent on Dolutegravir, highlight his role as an innovator in the field. His work continues to influence the development of effective treatments in medicine.